VIII / VIII / / PHARMACEUTICAL COMPOSITION FOR USE IN PREVENTION AND/OR TREATMENT OF DISEASE THAT DEVELOPS OR PROGRESSES AS A RESULT OF DECREASE OR LOSS OF ACTIVITY OF BLOOD COAGULATION FACTOR VIII AND/OR ACTIVATED BLOOD COAGULATION FACTOR VIII

摘要

Administering a pharmaceutical composition comprising a bispecific antigen binding molecule that recognizes Factor IX Factor and / or activated coagulation Factor IX and Factor X Factor and / or activated coagulation Factor X to a predetermined dosage regimen , It is possible to more effectively prevent and / or treat a disease which is caused and / or developed by the deterioration or deficiency of the activity of the blood coagulation factor VIII factor and / or the activated coagulation factor VIII factor.